Aristotle University Of Thessaloniki (AUTH)
Μελέτη της σχέσης του πολυμορφισμού C677T του γονιδίου της αναγωγάσης του μεθυλενοτετραϋδροφυλλικού οξέος ( MTHFR ) και της ανταπόκρισης στη θεραπεία με μεθοτρεξάτη παιδιών με αιματολογικές κακοήθειες από τη Β. Ελλάδα
Abstract
dc:descriptionThe present dissertation aimed at investigating the possible association of the 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism with response to chemotherapy of children patients with acute lymphoblastic leukemia (ALL) from northern Greece. The study was retrospective in nature and included a total of 46 children, all Greek nationals, who had been treated for ALL between 1997 and 2004 with the ALL-BFM90/95 protocol, in the 2nd Pediatric University Clinic of AHEPA Hospital and the Department of Pediatric Oncology of Hippokration Hospital, both at Thessaloniki, Greece. The study was focused exclusively in the induction and consolidation phases of chemotherapy. Evaluation of response in terms of liver and heamatologic toxicity as well as efficacy of chemotherapy was based on the distribution of serum levels of alanine aminotransferase (ALT), hemoglobin concentration (Hb), white blood cell counts (WBC) and platelet counts (PLT), calculated from the original data as they had been recorded in the patients’ files. Genotyping of the MTHFR C677T polymorphism was accomplished through an RFLP method based on PCR amplification of the relevant portion of the MTHFR gene followed by restriction digestion of the amplified DNA with Hinf1. The distributions of the aforementioned laboratory parameters were then compared between patients carriers and non-carriers of the MTHFR 677T allele, within and between phases of the ALLBFM90/ 95 protocol. Non-carriers of the T allele (CC homozygotes) displayed a general tendency towards lower values of all four parameters studied (ALT, Hb, WBC, PLT) within the same treatment phase (induction and/or consolidation). The same subgroup of patients appeared to display larger differences in the distribution of the same parameters between the two phases of treatment. The above results may to indicate that non-carriage of the MTHFR 677T allele is associated with better response of children patients to chemotherapy, during the initial phases of the ALL-FM90/95 protocol.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Chatzidakis, Konstantinos
- Χατζηδάκης, Κωνσταντίνος
Subjects
dc:subject × 12- Οξεία λεμφοβλαστική λευχαιμία
- Μεθοτρελάτη
- Γενετικός πολυμορφισμός
- Αναγωγάση 5, 10 μεθυλενοτετραϋδροφυλλικού οξέος
- Acute lymphoblastic leukaemia
- Methotrexate
- Gene polymorphisms
- 5, 10 methylenetetrahydrofolate reductase
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19612